You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

MECAMYLAMINE HYDROCHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Mecamylamine Hydrochloride, and when can generic versions of Mecamylamine Hydrochloride launch?

Mecamylamine Hydrochloride is a drug marketed by Lgm Pharma and is included in one NDA.

The generic ingredient in MECAMYLAMINE HYDROCHLORIDE is mecamylamine hydrochloride. There are three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the mecamylamine hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Mecamylamine Hydrochloride

A generic version of MECAMYLAMINE HYDROCHLORIDE was approved as mecamylamine hydrochloride by LGM PHARMA on March 19th, 2013.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for MECAMYLAMINE HYDROCHLORIDE?
  • What are the global sales for MECAMYLAMINE HYDROCHLORIDE?
  • What is Average Wholesale Price for MECAMYLAMINE HYDROCHLORIDE?
Drug patent expirations by year for MECAMYLAMINE HYDROCHLORIDE
Recent Clinical Trials for MECAMYLAMINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Vanderbilt University Medical CenterEarly Phase 1
Wayne State UniversityPhase 4
AstraZenecaPhase 2

See all MECAMYLAMINE HYDROCHLORIDE clinical trials

Pharmacology for MECAMYLAMINE HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for MECAMYLAMINE HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for MECAMYLAMINE HYDROCHLORIDE

US Patents and Regulatory Information for MECAMYLAMINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lgm Pharma MECAMYLAMINE HYDROCHLORIDE mecamylamine hydrochloride TABLET;ORAL 204054-001 Mar 19, 2013 RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.